- 期刊
- OpenAccess
Systemic Therapy for Elderly Patients with Gastrointestinal Cancer
並列摘要
The majority of patients with gastrointestinal cancers are over the age of 65. This age group comprises the minority of the patients enrolled in clinical trials, and it is unknown whether older patients achieve similar results as younger patients in terms of survival benefit and tolerability. In addition, there are few studies specifically designed for patients over 65 years. Subset analyses of individual trials and studies using pooled patient data from multiple trials provide some understanding on outcomes in older patients with gastrointestinal cancers. This article reviews the evidence on chemotherapeutic regimens in the elderly with colorectal, pancreatic, and gastroesophageal cancers, and discusses a practical approach to provide the best outcomes for older patients.
延伸閱讀
- 許駿（2004）。Study of Systemic Therapy for Hepatocellular Carcinoma〔博士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2004.01876
- Yada, T., Yokoi, C., & Uemura, N. (2013). The Current State of Diagnosis and Treatment for Early Gastric Cancer. Diagnostic and Therapeutic Endoscopy, 2013(), 31-39. https://doi.org/10.1155/2013/241320
- 葉忍莉、陸重隆（2001）。Gastrointestinal Medication Used in Terminal Cancer Patients。安寧療護雜誌，6(2)，27-31。https://doi.org/10.6537/TJHPC.2001.6(2).4
- Yeh, K. H., & Cheng, A. L. (2004). Recent Advances in Therapy for Gastric Cancer. Journal of the Formosan Medical Association, 103(3), 171-185. https://doi.org/10.29828/JFMA.200403.0002
- 姚鍾太、周繡玲（2009）。New Trends in the Treatment of Gastric Cancer。腫瘤護理雜誌，9(S)，37-50。https://doi.org/10.6880/TJON.200912/SP_9.04